geographical footprint analysis: Live & Latest News Updates : Vimarsana.com

The Worldwide Immuno-Oncology Assays Industry is Projected to Reach $7.9 Billion by 2026 at a CAGR of 12.5% from 2021

Share this article Share this article ResearchAndMarkets.com's offering. The global immuno-oncology assays market is projected to reach USD 7.9 billion by 2026 from USD 4.4 billion in 2021, at a CAGR of 12.5% during the forecast period. Market growth is driven by factors such as the growing significance of companion diagnostics in drug development and rising incidence of cancer and growing adoption of targeted therapies. On the other hand, the requirement of high capital investments and low cost-benefit ratio and the unfavorable regulatory and reimbursement scenario are the major factors hampering the growth of this market. The consumables segment accounted for the highest growth rate in the immuno-oncology assays market, by product & service, during the forecast period

The Worldwide Molecular Diagnostics Industry is Expected to Reach $31.8 Billion by 2026 at a CAGR of 12.3% from 2021

The Worldwide Molecular Diagnostics Industry is Expected to Reach $31.8 Billion by 2026 at a CAGR of 12.3% from 2021